Evidence map›Paper›PMID 29844044›Full record

ArticleAntimicrobial agents and chemotherapy2018

Antitrypanosomal 8-Hydroxy-Naphthyridines Are Chelators of Divalent Transition Metals.

Richard J Wall, Sonia Moniz, Michael G Thomas, Suzanne Norval, Eun-Jung Ko, Maria Marco, Timothy J Miles, Ian H Gilbert, David Horn, Alan H Fairlamb and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Antimicrobial Activity of Naphthyridine Derivatives.Pharmaceuticals (Basel, Switzerland) · 2024
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Richard J WallWellcome Trust Centre for Anti-Infectives Research, Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, Dundee, United Kingdom.
Sonia MonizWellcome Trust Centre for Anti-Infectives Research, Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, Dundee, United Kingdom.
Michael G ThomasWellcome Trust Centre for Anti-Infectives Research, Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, Dundee, United Kingdom.
Suzanne NorvalWellcome Trust Centre for Anti-Infectives Research, Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, Dundee, United Kingdom.
Eun-Jung KoWellcome Trust Centre for Anti-Infectives Research, Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, Dundee, United Kingdom.
Maria MarcoDiseases of the Developing World, GlaxoSmithKline, Madrid, Spain.
Timothy J MilesDiseases of the Developing World, GlaxoSmithKline, Madrid, Spain.
Ian H GilbertWellcome Trust Centre for Anti-Infectives Research, Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, Dundee, United Kingdom.
David HornWellcome Trust Centre for Anti-Infectives Research, Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, Dundee, United Kingdom.
Alan H FairlambWellcome Trust Centre for Anti-Infectives Research, Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, Dundee, United Kingdom.
Susan WyllieWellcome Trust Centre for Anti-Infectives Research, Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, Dundee, United Kingdom s.wyllie@dundee.ac.uk.
Wellcome Trust · GBGlaxoSmithKline (Spain) · ESUniversity of Dundee · GBWellcome Centre for Anti-Infectives Research · GB

Funding

Wellcome Trust 079838Wellcome Trust 092340Wellcome Trust 100320/Z/12/ZWellcome Trust 105021Wellcome Trust 203134Wellcome Trust 203134/Z/16/Z
6 · The paper itself

Abstract

The lack of information regarding the mechanisms of action (MoA) or specific molecular targets of phenotypically active compounds can prove a barrier to their development as chemotherapeutic agents. Here, we report the results of our orthogonal genetic, molecular, and biochemical studies to determine the MoA of a novel 7-substituted 8-hydroxy-1,6-naphthyridine (8-HNT) series that displays promising activity against

Indexed as

Antiprotozoal AgentsCations, DivalentCation Transport ProteinsChelating AgentsCopperGene ExpressionGolgi ApparatusIronLeishmania donovaniMutationNaphthyridinesParasitic Sensitivity TestsProtozoan ProteinsStructure-Activity RelationshipTrypanosoma brucei bruceiZincAntiprotozoal AgentsCations, DivalentCation Transport ProteinsChelating AgentsCopperIronNaphthyridinesProtozoan ProteinsZincchelatordrug discoverykinetoplastidsmechanisms of actiontransition metals

Identifiers

PMID29844044
PMCPMC6105827
OpenAlexW2803649410

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.